| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 26,591,000 | 24,645,000 | 24,752,000 | 24,124,000 | | Cost of Revenue | 10,308,000 | 9,976,000 | 10,048,000 | 9,466,000 | | | Gross Profit | 16,283,000 | 14,669,000 | 14,704,000 | 14,658,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,561,000 | 7,090,000 | 6,879,000 | 6,528,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,028,000 | 3,747,000 | 3,652,000 | 3,584,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,694,000 | 3,832,000 | 4,173,000 | 4,546,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 53,000 | 62,000 | 105,000 | 92,000 | | Earnings Before Interest And Taxes | 4,875,000 | 2,307,000 | 2,959,000 | 3,266,000 | | Interest Expense | 925,000 | 517,000 | 440,000 | 403,000 | | Income Before Tax | 3,950,000 | 1,790,000 | 2,519,000 | 2,863,000 | | Income Tax Expense | 740,000 | 555,000 | 850,000 | 981,000 | | Minority Interest |
-
| (1,696,000) | (1,530,000) | (1,522,000) | | | | Net Income From Continuing Ops | 3,210,000 | 1,235,000 | 1,669,000 | 1,882,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,210,000 | 1,235,000 | 1,669,000 | 1,882,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,210,000 | $1,235,000 | $1,669,000 | $1,882,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
